Francesco Carones, MD was born in Italy in 1963. He graduated in 1988 from the University of Milan, Italy, where he attended the Department of Ophthalmology as a resident. In 1992 he took a clinical training period focused on refractive surgery at Emory University, Atlanta GA, USA. Formerly he was Assistant Professor of Ophthalmology and Director of Refractive Surgery at the Department of Ophthalmology and Visual Sciences, S. Raffaele Hospital, University of Milan, Italy. Now in private practice, Dr. Carones is the co-founder, Medical Director and Physician CEO (Kellogg School of Management, Northwestern University, Evanston, Ill. USA) of the Carones Ophthalmology Center in Milan, Italy where he performs cataract and refractive surgery.
Dr. Carones is involved in refractive surgery since 1989 when he started pioneering the use of excimer laser. He participated in several clinical trials, including the first human study on hyperopia correction using erodible masks. He explored the application of mitomycin C after laser surgery. He was among the first to have access to the tracker-assisted flying-spot ablation technology and to propose LASEK. Currently, he is a clinical investigator for major surgical companies. As for cataract surgery, he was the first to implant a toric multifocal IOL, as well as a low power, add multifocal IOL. His cataract and refractive surgery practice also involve phakic IOLs, intracorneal ring segments, corneal inlays, corneal cross-linking, and refractive keratotomy.
Dr. Carones published many papers in peer-reviewed scientific journals, books and book chapters on refractive and cataract surgery and corneal topography. His research activities lead him to lecture and present at major meetings on refractive surgery worldwide, including AAO, ASCRS, ESCRS, and ISRS. He is Associate Editor of the Journal of Refractive surgery and member of the most important Editorial Boards. He currently serves as Board Member of several national and international Ophthalmology Societies, and Member of the Advisory Board of major ophthalmic companies.
